Inhibitor Therapeutics (INTI) Shares Outstanding (Entity) (2012 - 2026)
Inhibitor Therapeutics (INTI) posted Shares Outstanding (Entity) of 173.79 million for Q2 2026, up 0.7% from 172.57 million a year earlier and up 0.7% from the prior quarter.
Powered by 
Analysis
Inhibitor Therapeutics (INTI) Shares Outstanding (Entity) (2012 - 2026) Analysis & Trends
For FY2025, Inhibitor Therapeutics' Shares Outstanding (Entity) came in at 172.57 million, up 0.1% from FY2024.
- Annual Shares Outstanding (Entity) shows a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
- In prior years, Inhibitor Therapeutics' Shares Outstanding (Entity) was 172.32 million in FY2024 (+0.2%), 172.02 million in FY2023 (-53.0%), 366.18 million in FY2022 (-2.8%) and 376.86 million in FY2021 (+0.9%).
- The Q2 2026 figure stands as the highest quarterly Shares Outstanding (Entity) since Q4 2022.
- On a year-over-year basis, Shares Outstanding (Entity) has increased in each of the last five quarters, with growth averaging 0.2% over the last eight quarters.
- The strongest year-over-year quarter for Shares Outstanding (Entity) in the past five years was Q4 2021, with growth of 0.9%; the weakest was Q1 2023, with a decline of 54.4%.
- According to Business Quant data, Shares Outstanding (Entity) for the three prior quarters was 172.57 million (Q1 2026), 172.57 million (Q4 2025) and 172.57 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Inhibitor Therapeutics | 17.38 Mn | 17.38 Mn | - | 173.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 173.79 Mn |
| Mar 31, 2026 | 172.57 Mn |
| Dec 31, 2025 | 172.57 Mn |
| Sep 30, 2025 | 172.57 Mn |
| Jun 30, 2025 | 172.57 Mn |
| Mar 31, 2025 | 172.32 Mn |
| Dec 31, 2024 | 172.32 Mn |
| Sep 30, 2024 | 172.32 Mn |
| Jun 30, 2024 | 172.32 Mn |
| Mar 31, 2024 | 172.32 Mn |
| Dec 31, 2023 | 172.02 Mn |
| Sep 30, 2023 | 172.02 Mn |
| Jun 30, 2023 | 171.97 Mn |
| Mar 31, 2023 | 171.79 Mn |
| Dec 31, 2022 | 366.18 Mn |
| Sep 30, 2022 | 376.86 Mn |
| Jun 30, 2022 | 376.86 Mn |
| Mar 31, 2022 | 376.86 Mn |
| Dec 31, 2021 | 376.86 Mn |
| Sep 30, 2021 | 375.88 Mn |
API Access
Inhibitor Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=INTI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "INTI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=INTI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();